share_log

Astra vaccine guidance will have negligible impact on rollout -England's deputy chief medic

路透社 ·  Apr 7, 2021 23:01
LONDON, April 7 (Reuters) - Britain's recommendation against giving the Oxford-AstraZeneca COVID-19 vaccine to those aged under 30 due to the risk of blood clots will have a negligible impact on the vaccine programme, England's deputy chief medical officer Jonathan Van-Tam said.
   "Because of our supply situation in relation to alternative vaccines, the effect on the timing of our overall programme should be zero or negligible," he said at a briefing on Wednesday.

(Reporting by Guy Faulconbridge and Kate Holton, Writing by
Paul Sandle; editing by James Davey)
((paul.sandle@thomsonreuters.com; +44 20 7542 6843; Reuters
Messaging: paul.sandle.thomsonreuters.com@reuters.net)
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment